← Back to guidelines
Cardiology57 papers

Dengue hemorrhagic fever

Last edited: 4/15/2026

Overview

Dengue hemorrhagic fever (DHF) is a severe form of dengue infection characterized by increased vascular permeability, leading to plasma leakage, hemorrhagic manifestations, and potentially life-threatening complications such as dengue shock syndrome and disseminated intravascular coagulation (DIC). 1

Diagnosis

  • Clinical Presentation: High fever, hemorrhagic manifestations, thrombocytopenia, and evidence of plasma leakage (e.g., pleural effusion, ascites).
  • Laboratory Tests:
  • - Low platelet count (<150,000/μL). - Increased hematocrit or hemoconcentration. - Presence of dengue-specific antibodies or viral RNA in blood.
  • Grading: WHO classification includes grades I-IV based on severity, with grade III and IV indicating DHF and dengue shock syndrome, respectively.
  • Management

  • First-Line Treatments:
  • - Supportive Care: Fluid replacement to manage hypovolemic shock and correct electrolyte imbalances. - Monitoring: Close observation for signs of shock, organ failure, and DIC.
  • Adjunctive Treatments:
  • - Corticosteroids: Pulse methylprednisolone may be considered in severe cases with multiorgan involvement. 1 - Intravenous Immunoglobulin (IVIG): High-dose IVIG has shown efficacy in managing severe complications like hemophagocytic syndrome. 1

    Special Populations

  • Adult Cases: Hemophagocytic syndrome can complicate adult DHF, necessitating early diagnosis and aggressive treatment with pulse methylprednisolone and IVIG. 1
  • Key Recommendations

  • Early Recognition and Supportive Care: Prompt identification and management of fluid balance and hemodynamic stability are crucial in DHF management. (Evidence: Moderate) 1
  • Consider Corticosteroids and IVIG for Severe Complications: In cases with severe multiorgan involvement, such as hemophagocytic syndrome, pulse methylprednisolone and high-dose IVIG may improve outcomes. (Evidence: Weak) 1
  • Close Monitoring for DIC and Organ Failure: Regular monitoring for signs of disseminated intravascular coagulation and organ dysfunction is essential in guiding treatment adjustments. (Evidence: Expert opinion) 1
  • References

    1 Srichaikul T, Punyagupta S, Kanchanapoom T, Chanokovat C, Likittanasombat K, Leelasiri A. Hemophagocytic syndrome in Dengue hemorrhagic fever with severe multiorgan complications. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2008. link

    Original source

    1. [1]
      Hemophagocytic syndrome in Dengue hemorrhagic fever with severe multiorgan complications.Srichaikul T, Punyagupta S, Kanchanapoom T, Chanokovat C, Likittanasombat K, Leelasiri A Journal of the Medical Association of Thailand = Chotmaihet thangphaet (2008)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG